Arkema SA (OTCMKTS:ARKAY – Get Free Report) saw a significant decline in short interest during the month of September. As of September 30th, there was short interest totaling 36 shares, a decline of 98.1% from the September 15th total of 1,858 shares. Based on an average trading volume of 1,892 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.
Analyst Upgrades and Downgrades
ARKAY has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Arkema in a research report on Tuesday, June 23rd. Barclays upgraded shares of Arkema from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 12th. Six investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce”.
Get Our Latest Analysis on Arkema
Arkema Stock Up 0.7%
Arkema (OTCMKTS:ARKAY – Get Free Report) last released its earnings results on Thursday, July 30th. The basic materials company reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.86 by $0.12. Arkema had a return on equity of 4.30% and a net margin of 0.67%. The business had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.86 billion. Sell-side analysts predict that Arkema will post 3.73 earnings per share for the current fiscal year.
About Arkema
Arkema is a France-based specialty materials company that develops and manufactures materials used in a broad range of industrial and consumer applications. Its portfolio includes high-performance polymers, adhesives, coating materials, additives and specialty chemical intermediates.
The company’s businesses serve markets such as construction, automotive, electronics, renewable energy, consumer goods, packaging and healthcare. Arkema’s brands and product lines include Bostik adhesives, Kynar fluoropolymers, Rilsan polyamide materials, Pebax elastomers and Sartomer specialty resins and additives.
Arkema was established in 2004 through the reorganization of Total’s chemicals businesses and became an independent, publicly traded company in 2006.
See Also
- Five stocks we like better than Arkema
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
